Skip to main content
    S

    STRATA Skin Sciences Inc (SSKN)

    Official site

    MEDICAL DEVICES

    $0.00
    +0.00 (+0.00%)

    Last updated: Nov 13, 2026 at 4:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    53%(18/34)
    Avg Surprise
    +10.02%
    Last 12 of 36 reported quarters
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Sep 25
    Reported Nov 13
    -$0.36$0.03N/A--1
    0
    1
    30d
    +30.9%
    Jun 25
    Reported Aug 13
    -$0.60$0.01N/A--1
    0
    1
    30d
    -1900.0%
    Mar 25
    Reported May 14
    -$0.58-$0.56-$0.56 - -$0.56-3.57%Miss1
    0
    1
    30d
    -480.0%
    Dec 24
    Reported Mar 27
    $0.29-$0.40-$0.40 - -$0.40+171.80%Beat1
    1
    0
    30d
    +361.1%
    Sep 24
    Reported Nov 13
    -$0.52-$0.44-$0.44 - -$0.44-18.34%Miss1
    No revisions (30d)
    -1635.7%
    Jun 24
    Reported Aug 14
    -$0.03-$0.70-$0.80 - -$0.60+95.71%Beat2
    No revisions (30d)
    +50.0%
    Mar 24
    Reported May 15
    -$0.10-$0.07-$0.07 - -$0.07-42.86%Miss1
    No revisions (30d)
    -25.0%
    Dec 23
    Reported Mar 27
    -$0.11-$0.02-$0.02 - -$0.02-450.00%Miss2
    No revisions (30d)
    -344.4%
    Sep 23
    Reported Nov 14
    -$0.03-$0.04-$0.04 - -$0.04+25.00%Beat2
    No revisions (30d)
    +0.0%
    Jun 23
    Reported Aug 9
    -$0.06-$0.05-$0.07 - -$0.04-20.00%Miss2
    0
    1
    30d
    -20.0%
    Mar 23
    Reported May 15
    -$0.08-$0.07-$0.09 - -$0.05-14.29%Miss2
    No revisions (30d)
    -14.3%
    Dec 22
    Reported Mar 31
    $0.05-$0.05-$0.07 - -$0.03+190.00%Beat2
    No revisions (30d)
    +325.0%

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF-0.00xFCF Yield-744540.05%
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROIC-20.34%
    Financial Health
    Debt/Equity5.28xInterest Coverage-2.40x
    Current Ratio0.58xQuick Ratio0.48x
    Trading Statistics
    BetaN/AAvg Volume10.95K
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 94.0% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 30.8, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$0.00
    SMA 20$0.00
    SMA 50$0.00
    SMA 200$0.14
    EMA 10$0.00
    EMA 20$0.00
    EMA 50$0.01
    EMA 200$0.30

    MACD

    Line: -0.00Signal: -0.00Hist: 0.00

    ADX

    ADX: 35.7+DI: 29.7-DI: 62.7

    Aroon & PSAR

    Aroon Up56.0
    Aroon Down68.0
    PSAR$0.00

    Bollinger Bands

    Upper Band$0.00
    Lower BandN/A
    %B Position28920%(Upper)
    Band Width0.48

    RSI (14-Day)

    Neutral
    30.8

    Momentum Oscillators

    Stoch %K50.0
    Stoch %D50.0
    Williams %R-50.0
    ROC (10d)N/A
    MomentumN/A
    CCI (20d)-7.9
    MFI (14d)0.9

    Volatility Measures

    ATR (14d)$0.00(115.7%)
    StdDev (20d)0.00
    Hist VolN/A

    Volume Flow

    VWAP$0.00
    OBV264.2M
    AD Line-73.6M
    CMF (20d)-0.013

    Volume Metrics

    Avg Vol (20d)8.2K
    Vol Ratio1.5x
    VWMA (20d)$0.00

    Pivot Points

    R3$0.00
    R2$0.00
    R1$0.00
    Pivot Point$0.00
    S1$0.00
    S2$0.00
    S3$0.00

    Advanced Oscillators

    TSI-40.72
    Ultimate OscN/A
    KSTN/A

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about SSKN

    News

    No news available

    Company news will appear here when available

    SSKN Valuation

    P/FCF
    -0.0x
    P/B
    0.0x
    All SSKN metrics

    SSKN Profitability: Margins, ROIC and FCF

    STRATA Skin Sciences (SSKN) has a gross margin of 58.3%. It posts -20.3% ROIC and a -14.3% FCF margin.

    Gross margin
    58.3%
    ROIC
    -20.3%
    FCF margin
    -14.3%
    FCF yield
    -744540.1%
    SSKN financial statements

    STRATA Skin Sciences Competitors

    Peers by sector and size for STRATA Skin Sciences (SSKN) include Jasper Therapeutics, DIH Holdings US, Inc. Class A Common Stock and Protagenic Therapeutics.

    Sector: Healthcare

    SSKN Bull Case vs Bear Case

    Bear case

    • SSKN beat EPS estimates in 37.5% of its last 8 reported quarters.
    • SSKN has a debt-to-equity ratio of 5.3x.

    SSKN Earnings: Beat Rate

    The next report from STRATA Skin Sciences (SSKN) is expected on Mar 24, 2027.

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -30.3%

    SSKN Earnings Date

    SSKN reports Mar 24, 2027. The date is estimated.

    SSKN Earnings Call

    The latest SSKN earnings call transcript on file is labeled 2025Q3.

    Read the 2025Q3 transcript

    See insider activity

    Updated Mar 31, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About SSKN

    When does SSKN report earnings?

    STRATA Skin Sciences Inc (SSKN) is expected to report earnings on Mar 24, 2027.

    Does SSKN pay dividends?

    STRATA Skin Sciences Inc (SSKN) does not currently pay a regular dividend.

    SSKN pages: Overview, Financials

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.